课题基金 / 基金详情

DIAGNOSTICS FOR IVERMECTIN RESISTANCE IN NEMATODES

DIAGNOSTICS FOR IVERMECTIN RESISTANCE IN NEMATODES
线虫对伊维菌素耐药性的诊断
批准号:
3489564
负责人:
CARL D JOHNSON
金额:
$5.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-03-01 至 1992-08-31

项目摘要

项目成果

CARL D JOHNSON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from the applicant's abstract) Recently, resistance to anthelmintics has emerged as the most important problem confronting the control of parasitic nematodes of ruminants. Resistance in parasites of other economically significant animals has also been reported and there can be little doubt that the incidence of resistance will increase and eventually also appear in medically important parasites of man. The impact of resistance has been contained by the introduction of ivermectin, the most potent and arguably the most efficacious anthelmintic ever developed. However, recent reports suggest that development of resistance may soon reduce its value. Extensive investigations of ivermectin resistance in the model nematode Caenorhabditis elegans have generated a specific hypothesis regarding the likely form of ivermectin resistance in parasitic nematodes. The goals of the proposed Phase I research are to test the hypothesis and to identify the genes responsible for ivermectin resistance in parasitic nematodes. During Phase II these genes will be cloned and diagnostic reagents capable of detecting ivermectin resistance in parasites will be developed. Diagnostic reagents will provide early warning of emerging resistance and an ability to monitor the efficacy of new methods designed to limit, and preferably reverse, the growth of ivermectin resistant populations (Phase III).
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Wild-type and transactivation-defective mutants of human immunodeficiency virus type 1 Tat protein bind human TATA-binding protein in vitro.
人类免疫缺陷病毒 1 型 Tat 蛋白的野生型和反式激活缺陷突变体在体外与人 TATA 结合蛋白结合。
DOI: 10.1097/00042560-199606010-00005
发表时间: 1996
期刊: Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association
影响因子: --
作者: [Wang,Z, Morris,GF, Rice,AP, Xiong,W, Morris,CB]
通讯作者: Morris,CB
IMPROVING C ELEGANS BASED APOPTOSIS DRUG SCREENS
  • 批准号:
    2331087
  • 项目类别:
  • 资助金额:
    $10.0万
  • 财政年份:
    1996
  • 负责人:
    CARL D JOHNSON
  • 依托单位:
NOVEL NEMATODE-BASED SCREEN FOR ANTICANCER AGENTS
  • 批准号:
    2105945
  • 项目类别:
  • 资助金额:
    $6.87万
  • 财政年份:
    1994
  • 负责人:
    CARL D JOHNSON
  • 依托单位:
IDENTIFYING HUMAN HOMOLOGUES OF C. ELEGANS GENE
  • 批准号:
    3505354
  • 项目类别:
  • 资助金额:
    $5.0万
  • 财政年份:
    1992
  • 负责人:
    CARL D JOHNSON
  • 依托单位:
NOVEL NEMATODE SPECIFIC ANTHELMINTICS AND NEMATICIDES
  • 批准号:
    3488671
  • 项目类别:
  • 资助金额:
    $4.94万
  • 财政年份:
    1988
  • 负责人:
    CARL D JOHNSON
  • 依托单位:
海外基金